You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

ESTROGEL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Estrogel, and when can generic versions of Estrogel launch?

Estrogel is a drug marketed by Ascend Theraps Us and is included in one NDA.

The generic ingredient in ESTROGEL is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Estrogel

A generic version of ESTROGEL was approved as estradiol by BARR LABS INC on October 22nd, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ESTROGEL?
  • What are the global sales for ESTROGEL?
  • What is Average Wholesale Price for ESTROGEL?
Drug patent expirations by year for ESTROGEL
Drug Sales Revenue Trends for ESTROGEL

See drug sales revenues for ESTROGEL

Recent Clinical Trials for ESTROGEL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
FundaciĆ³n Santiago Dexeus FontPhase 3
Hamad Medical CorporationPhase 2
Laboratoires Besins InternationalPhase 2

See all ESTROGEL clinical trials

Pharmacology for ESTROGEL
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists

US Patents and Regulatory Information for ESTROGEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascend Theraps Us ESTROGEL estradiol GEL, METERED;TRANSDERMAL 021166-002 Feb 9, 2004 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ascend Theraps Us ESTROGEL estradiol GEL;TOPICAL 021166-001 Feb 9, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.